A previous study identified a new Treg subpopulation, CD13-expressing CD4+CD25high Tregs, among CD4+CD25high Tregs in the peripheral blood of patients with non-small cell lung cancer and found that CD13+ Tregs with high levels of Foxp3 expression exhibited enhanced immunosuppressive functions16. The gene discussed is CD4; the disease is non-small cell lung carcinoma.